Intensity Therapeutics, Inc. INTS 深 滬
等待開盤 07-22 09:30:00 美东时间
0.3184
-0.007
-2.03%
華盛通- 最 高0.335
- 今 開0.33
- 成交量 333.44万股
- 最 低 0.3005
- 昨 收 0.325
- 總市值 798.33万
- 52周最高 4.9399
- 市盈率 靜 --
- 換手率 13.30%
- 52周最低 0.2602
- 委 比 75.00%
- 總股本 2507.32万
- 歷史最高 11.44
- 量 比 0.89
- 振 幅 10.62%
- 歷史最低 0.2602
- 每 手 1
- 風險率 1.23%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Oncology Innovation Just Hit a Turning Point -- Here's What to Watch
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- USA News Group News Commentary – The oncology landscape is being pulle...
06-30 23:02
Intensify Therapeutics slumps 27%, prices $2M stock offering
Intensity Therapeutics (NASDAQ:INTS) stock price slumped 27% on Wednesday during after market hours of trading as it priced an underwritten public offering of ~6.68M shares at $0.30 per share, for g...
06-12 14:52
Intensity Therapeutics, Inc. Announces Pricing of Public Offering
SHELTON, Conn., June 11, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery...
06-12 11:46
Intensity Therapeutics shares are trading higher after the company announced the first few patients receiving INT230-6 achieved high levels of necrosis after 8 days in the Phase 2, INVINCIBLE-4 study.
Intensity Therapeutics shares are trading higher after the company announced th...
06-12 01:15
Intensity Therapeutics Faces Nasdaq Delisting Notice
The latest announcement is out from Intensity Therapeutics, Inc. ( ($INTS) ). O...
06-07 05:29
Bell Media Announces 2025/26 Original Content Slate
– Bell Media's initial 2025/26 slate includes 116 titles, a nearly 20% increase over last year – – More titles to be announced later this year – Key Tags: @BellMediaPR, @TheLede_CA TORONTO, ...
06-05 19:30
Reported Earlier: Intensity Therapeutics To Present Phase 3 INVINCIBLE-3 Trial Poster For INT230-6 In Metastatic Soft Tissue Sarcomas At ASCO 2025 Annual Meeting
Intensity Therapeutics, Inc.
05-29 23:15
因股价表现滞后 强度治疗公司股票锁定期将于5月25日届满
强度治疗公司（Intensity Therapeutics Inc．）在完成 235 万美元的增发后，其股票锁定期将于 5 月 25 日到期。 承销商此...
05-18 19:06
Intensity Therapeutics Q1 EPS $(0.22) Misses $(0.20) Estimate
Intensity Therapeutics (NASDAQ:INTS) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.20) by 10 percent. This is a 35.29 percent increase over losses of $(0.34) per share
05-14 04:35
Why Intensity Therapeutics (INTS) Stock Is Getting Hammered
Intensity Therapeutics shares are trading lower by 34.9% during Friday's session. The company announced the pricing of a public offering expected to raise approximately $2.35 million.
04-25 21:22
